Investigation of genotype-phenotype and familial features of Turkish dystrophinopathy patients.

[1]  P. Shieh,et al.  Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double‐blind, placebo‐controlled, dose‐titration trial , 2021, Muscle & nerve.

[2]  T. Delhaas,et al.  Mutation pattern in 606 Duchenne muscular dystrophy children with a comparison between familial and non-familial forms: a study in an Indian large single-center cohort , 2019, Journal of Neurology.

[3]  V. Chandru,et al.  Multi-gene testing in neurological disorders showed an improved diagnostic yield: data from over 1000 Indian patients , 2019, Journal of Neurology.

[4]  H. Kayserili,et al.  Mutation spectrum of 260 dystrophinopathy patients from Turkey and important highlights for genetic counseling , 2019, Neuromuscular Disorders.

[5]  M. Falzarano,et al.  Duchenne Muscular Dystrophy: From Diagnosis to Therapy , 2015, Molecules.

[6]  M. Baiget,et al.  DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations , 2015, PloS one.

[7]  B. Darras,et al.  Dystrophinopathies , 2015, Seminars in Neurology.

[8]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[9]  Angshuman Bagchi,et al.  Analyses of the presence of mutations in Dystrophin protein to predict their relative influences in the onset of Duchenne Muscular Dystrophy. , 2014, Cellular signalling.

[10]  G. Comi,et al.  6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes , 2014, PloS one.

[11]  Y. Takeshima,et al.  Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients , 2013, Journal of Human Genetics.

[12]  L. Rohde,et al.  Prevalence and diagnostic stability of ADHD and ODD in Turkish children: a 4-year longitudinal study , 2013, Child and Adolescent Psychiatry and Mental Health.

[13]  X. Yi,et al.  Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMD/BMD: a multi-population diagnostic study , 2013, European Journal of Human Genetics.

[14]  Craig McDonald,et al.  LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy , 2013, Annals of neurology.

[15]  Fei Chen,et al.  MLPA-based genotype–phenotype analysis in 1053 Chinese patients with DMD/BMD , 2013, BMC Medical Genetics.

[16]  E. Bertini,et al.  Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. , 2012, The Journal of pediatrics.

[17]  Cindy Hamil,et al.  Evidence‐based path to newborn screening for duchenne muscular dystrophy , 2012, Annals of neurology.

[18]  Anna Carla Turconi,et al.  Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up , 2011, Journal of Neurology.

[19]  V. Ricotti,et al.  Dystrophin and the brain , 2011, Developmental medicine and child neurology.

[20]  Christophe Béroud,et al.  Genotype–phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD–DMD database: a model of nationwide knowledgebase , 2009, Human mutation.

[21]  J. Houwing-Duistermaat,et al.  Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy , 2009, Clinical genetics.

[22]  J. Vles,et al.  Neuropsychiatric Disorders in Males With Duchenne Muscular Dystrophy: Frequency Rate of Attention-Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, and Obsessive—Compulsive Disorder , 2008, Journal of child neurology.

[23]  C. Béroud,et al.  Protein‐ and mRNA‐based phenotype–genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene , 2007, Human mutation.

[24]  G. van Ommen,et al.  Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame rule , 2006, Muscle & nerve.

[25]  M. Claustres,et al.  An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements. , 2006, Human molecular genetics.

[26]  F. Muntoni,et al.  Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion , 2003, Journal of medical genetics.

[27]  R. Hofstra,et al.  Detection of point mutation in dystrophin gene reveals somatic and germline mosaicism in the mother of a patient with Duchenne muscular dystrophy , 2003, American journal of medical genetics. Part A.

[28]  D. Zwijnenburg,et al.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.

[29]  N. Ryan,et al.  Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[30]  G. Danieli,et al.  Duchenne phenotype with in‐frame deletion removing major portion of dystrophin rod: Threshold effect for deletion size? , 1996, Muscle & nerve.

[31]  D. Bentley,et al.  Exon structure of the human dystrophin gene. , 1993, Genomics.

[32]  C. Mathew,et al.  A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods. , 1991, Journal of medical genetics.

[33]  R A Gibbs,et al.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. , 1988, Nucleic acids research.

[34]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[35]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[36]  A. Monaco,et al.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. , 1988, Genomics.

[37]  K. Bushby,et al.  This Work Is Licensed under a Creative Commons Attribution 4.0 International License the Treat-nmd Dmd Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations , 2022 .